Stryker Corporation $SYK Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC reduced its stake in shares of Stryker Corporation (NYSE:SYK) by 5.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 3,117,283 shares of the medical technology company’s stock after selling 192,839 shares during the quarter. Fisher Asset Management LLC’s holdings in Stryker were worth $1,095,632,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. United Financial Planning Group LLC acquired a new position in Stryker during the 3rd quarter worth $27,000. CGC Financial Services LLC acquired a new position in Stryker during the 4th quarter worth $29,000. Strive Asset Management LLC acquired a new position in Stryker during the 3rd quarter worth $30,000. ANTIPODES PARTNERS Ltd acquired a new position in Stryker during the 3rd quarter worth $34,000. Finally, Copia Wealth Management grew its holdings in Stryker by 181.6% during the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after acquiring an additional 69 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SYK. TD Cowen downgraded shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target on the stock. in a research report on Monday, January 26th. Jefferies Financial Group restated a “buy” rating and issued a $465.00 price target on shares of Stryker in a research report on Wednesday, March 4th. Needham & Company LLC reduced their price target on shares of Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Leerink Partners began coverage on shares of Stryker in a research report on Monday, April 13th. They issued an “outperform” rating and a $410.00 price target on the stock. Finally, The Goldman Sachs Group restated a “neutral” rating and issued a $361.00 price target on shares of Stryker in a research report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Insiders Place Their Bets

In related news, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president directly owned 177 shares in the company, valued at $50,170.65. This trade represents a 95.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.60% of the stock is currently owned by corporate insiders.

Stryker Trading Down 0.0%

Shares of NYSE:SYK opened at $316.39 on Monday. The company has a market cap of $121.29 billion, a PE ratio of 36.62, a P/E/G ratio of 1.99 and a beta of 0.80. The company’s 50-day moving average price is $325.22 and its 200 day moving average price is $349.76. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Sell-side analysts anticipate that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a $0.88 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.